Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

BIOMBIOMOLECULAR LIFE HOLDINGS, INC.

OTC · CIK 0001091326
Filer categorySmaller reporting company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts127

Identity from submissions API

NameBIOMOLECULAR LIFE HOLDINGS, INC.
CIK0001091326
TickersBIOM
ExchangesOTC
Entity typeoperating
CategorySmaller reporting company
SIC2834 Pharmaceutical Preparations
EIN330814123
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone805-879-9000
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • SB Technology Holdings, Inc. (2026-05-04T00:00:00.000Z → 2026-05-04T00:00:00.000Z)
  • VG Life Sciences Inc. (2014-11-13T00:00:00.000Z → 2026-03-06T00:00:00.000Z)
  • VG Life Sciences, Inc. (2014-06-20T00:00:00.000Z → 2014-10-14T00:00:00.000Z)
  • VIRAL GENETICS INC /DE/ (2002-04-01T00:00:00.000Z → 2009-03-25T00:00:00.000Z)
  • 5 STARLIVING ONLINE INC (1999-07-29T00:00:00.000Z → 2001-10-18T00:00:00.000Z)
Business address
888 BRICKELL KEY DR,
# 306,
MIAMI
FL
33131
FL
Mailing address
888 BRICKELL KEY DR,
# 306,
MIAMI
FL
33131
FL

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

211 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-10-22 10-12G/A 10-12G/A 0001493152-26-047964 000-26875 261477078 34 18302046
2026-10-14 10-12G/A 10-12G/A 0001493152-26-046957 000-26875 261459178 34 18300657
2026-09-29 10-12G/A 10-12G/A 0001493152-26-044715 000-26875 261418986 34 1079792
2026-08-26 10-12G 10-12G 0001493152-26-040114 000-26875 261317146 34 92646038
2026-05-04 RW RW 0001493152-26-021139 000-26875 26941444 NE 15257
2026-03-06 10-12G 10-12G 0001493152-26-009077 000-26875 26729408 34 99775383
2018-08-15 15-12G form15-12g.htm 0001493152-18-011973 000-26875 181019770 34 17153
2016-03-30 NT 10-K NOTICE OF LATE FILING 0001019687-16-005665 000-26875 161539383 34 18361
2016-03-30 8-K VG LIFE SCIENCES, INC. 5.02 0001019687-16-005617 000-26875 161536481 34 18272
2015-11-19 10-Q QUARTERLY REPORT 0001019687-15-004252 000-26875 151243887 34 1479042 1
2015-11-16 NT 10-Q NT 10-Q 0001019687-15-004151 000-26875 151235680 34 15669
2015-08-19 10-Q FORM 10-Q 0001019687-15-003202 000-26875 151064177 34 1610108 1
2015-08-14 NT 10-Q NOTICE OF LATE FILING 0001019687-15-003135 000-26875 151055855 34 16969
2015-05-21 8-K FORM 8-K 1.01,9.01 0001019687-15-002082 000-26875 15882982 34 26484
2015-05-20 10-Q VG LIFE SCIENCES INC. 0001019687-15-002045 000-26875 15879638 34 1590510 1
2015-05-18 8-K CURRENT REPORT 1.02,9.01 0001019687-15-002009 000-26875 15874254 34 43113
2015-05-15 NT 10-Q NOTICE OF LATE FILING 0001019687-15-001987 000-26875 15869618 34 16966
2015-04-15 10-K ANNUAL REPORT 0001019687-15-001463 000-26875 15772129 34 7225894 1
2015-03-31 NT 10-K NOTICE OF LATE FILING 0001019687-15-001183 000-26875 15736520 34 18071
2015-02-12 424B3 PROSPECTUS 0001019687-15-000569 333-201905 15606699 33 1917020
2015-02-11 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2015-02-11 17:00:00 9999999995-15-000397 333-201905 15601561 33 1984
2015-02-11 S-1/A FORM S-1 AMENDMENT 0001019687-15-000551 333-201905 15599515 33 2183891
2015-02-06 S-1 FORM S-1 0001019687-15-000466 333-201905 15582146 33 5737461 1
2015-02-06 RW REQUEST FOR WITHDRAWAL 0001019687-15-000462 333-200589 15581359 NE 6548
2015-01-22 8-K CURRENT REPORT ON FORM 8-K 1.01,3.02,5.02,9.01 0001019687-15-000296 000-26875 15541841 34 242083
2015-01-20 S-1/A S-1/A 0001019687-15-000238 333-200589 15533597 33 5728007 1
2014-11-25 S-1 VG LIFE SCIENCES INC. 0001019687-14-004506 333-200589 141250131 33 5432197 1
2014-11-13 10-Q FORM 10-Q 0001019687-14-004238 000-26875 141218338 34 2419220 1
2014-10-14 UPLOAD filename1.pdf 0000000000-14-051280 36571
2014-10-01 CORRESP filename1.htm 0001019687-14-003750 55467
2014-10-01 10-12G/A AMENDMENT #2 0001019687-14-003749 000-26875 141133873 34 2304165
2014-09-24 UPLOAD filename1.pdf 0000000000-14-047894 141789
2014-09-11 8-K CURRENT REPORT ON FORM 8-K 5.03 0001019687-14-003552 000-26875 141098273 34 16186
2014-09-10 CORRESP filename1.htm 0001019687-14-003530 57114
2014-09-10 10-12G/A 10-12G/A 0001019687-14-003529 000-26875 141096048 34 2321820
2014-07-22 UPLOAD filename1.pdf 0000000000-14-036827 188723
2014-06-20 10-12G FORM 10 0001019687-14-002510 000-26875 14934148 34 14581451
2009-03-25 15-12G c32590f1512g.htm 0001214659-09-000675 000-26875 09703642 34 19747
2009-02-17 8-K c139018k.htm 3.02 0001214659-09-000300 000-26875 09606773 34 25297
2008-11-18 8-K s1116818k.htm 1.01,2.01,2.03,3.02,5.02,8.01,9.01 0001214659-08-002537 000-26875 081196522 34 541744
2008-09-02 8-K f821818k.htm 1.01,3.02,9.01 0001214659-08-002004 000-26875 081052199 34 50452
2008-08-08 8-K s81818k.htm 3.02 0001214659-08-001787 000-26875 081002579 34 39467
2008-07-08 8-K f617808k.htm 2.01,3.02,9.01 0001214659-08-001555 000-26875 08943145 34 485133
2008-03-25 NT 10-K FOR PERIOD ENDED: DECEMBER 31, 2007 0001214659-08-000661 000-26875 08710033 34 23938
2007-12-20 8-K c1217738k.htm 1.01,2.03,3.02,9.01 0001214659-07-002693 000-26875 071317485 34 557615
2007-11-20 10QSB a11197010qsb.htm 0001214659-07-002491 000-26875 071259219 34 604824
2007-11-15 NT 10-Q FOR PERIOD ENDED SEPTMEBER 30, 2007 0001214659-07-002460 000-26875 071247632 34 15110
2007-11-01 4 PRIMARY DOCUMENT 0001243428-07-000004 5574
2007-10-02 8-K f911718k.htm 3.02,5.02,9.01 0001214659-07-002165 000-26875 071149621 34 172533
2007-09-28 8-K f926718k.htm 8.01,9.01 0001214659-07-002155 000-26875 071141831 34 252073
2007-09-25 3 PRIMARY DOCUMENT 0001411704-07-000002 10133
2007-08-20 10QSB FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2007 0001214659-07-001907 000-26875 071067970 34 615788
2007-08-15 NT 10-Q m81473nt10q.htm 0001214659-07-001863 000-26875 071059012 34 11464
2007-07-16 S-8 c71670s8.htm 0001214659-07-001592 333-144622 07982335 33 221478
2007-07-03 8-K viral-8k_061907.htm 3.02,5.02,9.01 0001020488-07-000116 000-26875 07956652 34 88603
2007-06-29 4 PRIMARY DOCUMENT 0001278334-07-000001 5596
2007-06-29 4 PRIMARY DOCUMENT 0001243428-07-000003 14550
2007-06-28 4 PRIMARY DOCUMENT 0001243428-07-000002 5628
2007-05-21 10QSB FOR PERIOD ENDING MARCH 31, 2007 0001214659-07-001197 000-26875 07868604 34 561338
2007-05-15 NT 10-Q m5157212b25.htm 0001214659-07-001152 000-26875 07852334 34 11580
2007-04-27 10KSB viral-10ksb_123106.htm 0001020488-07-000087 000-26875 07792584 34 548774
2007-03-30 NT 10-K viral-nt10k_123106.htm 0001020488-07-000050 000-26875 07730073 34 9654
2007-03-09 4 PRIMARY DOCUMENT 0001243428-07-000001 13565
2007-03-08 8-K viral-8k_030207.htm 1.01,3.02,9.01 0001020488-07-000042 000-26875 07679905 34 76438
2007-03-08 424B3 viral-424b3_030807.htm 0001020488-07-000040 333-134185 07679815 33 21876
2007-02-09 8-K viral-8k_020907.htm 8.01 0001020488-07-000024 000-26875 07595987 34 12845
2007-01-03 424B3 viral-424b3_010307.htm 0001020488-07-000002 333-134185 07501505 33 17728
2006-12-19 4 PRIMARY DOCUMENT 0001278334-06-000001 4874
2006-12-12 8-K FORM 8-K 8.01,9.01 0001193125-06-251294 000-26875 061270658 34 766079
2006-12-01 424B3 viral-424b3_120106.htm 0001020488-06-000262 333-134185 061249130 33 17665
2006-11-14 10QSB viral-10qsb_093006.htm 0001020488-06-000244 000-26875 061215922 34 151752
2006-11-08 8-K viral-8k_110706.htm 8.01,9.01 0001020488-06-000240 000-26875 061195195 34 1707113
2006-11-01 424B3 viral-424b3_110106.htm 0001020488-06-000237 333-134185 061179687 33 17313
2006-10-04 424B3 viral-424b3_100406.htm 0001020488-06-000214 333-134185 061127246 33 17297
2006-09-12 4 PRIMARY DOCUMENT 0001327918-06-000001 4895
2006-08-31 424B3 viral-424b3_083106.htm 0001020488-06-000204 333-134185 061067246 33 16426
2006-08-14 10QSB viral-10qsb_063006.htm 0001020488-06-000190 000-26875 061027848 34 166810
2006-08-07 EFFECT xslEFFECTX01/primary_doc.xml SB-2, 9999999995-06-001082 333-134185 061010796 33 2111
2006-08-07 424B3 FORM 424(B)(3) 0001193125-06-163307 333-134185 061007754 33 1121119
2006-08-03 UPLOAD filename1.pdf 0000000000-06-036837 11334
2006-08-03 SB-2/A SB-2/A PRE-EFFECTIVE AMENDMENT #1 0001193125-06-160875 333-134185 061001982 33 1262104
2006-08-03 10QSB/A FORM 10-QSB/A 0001193125-06-160045 000-26875 06999931 34 315635
2006-08-03 10KSB/A FORM 10-KSB/A 0001193125-06-160035 000-26875 06999929 34 796464
2006-08-03 CORRESP filename1.htm 0001193125-06-160007 19525
2006-07-26 CORRESP filename1.htm 0001020488-06-000175 15033
2006-06-19 8-K viral-8k_061906.htm 8.01,9.01 0001020488-06-000150 000-26875 06913258 34 27251
2006-06-16 UPLOAD filename1.pdf 0000000000-06-028395 15074
2006-05-26 10KSB/A viral-10ksba_123104.htm 0001020488-06-000134 000-26875 06870359 34 168768
2006-05-25 UPLOAD filename1.txt 0000000000-06-024858 5543
2006-05-16 SB-2 FORM SB-2 0001193125-06-113994 333-134185 06847125 33 1251781
2006-05-16 10QSB FORM 10-QSB 0001193125-06-113968 000-26875 06846986 34 321723
2006-05-16 10KSB/A FORM 10-KSB/A 0001193125-06-113958 000-26875 06846923 34 780684
2006-05-16 NT 10-Q viral-nt10q_033106.htm 0001020488-06-000115 000-26875 06843275 34 10271
2006-05-15 CORRESP filename1.htm 0001193125-06-113043 51599
2006-04-21 10KSB FORM 10-KSB 0001193125-06-084856 000-26875 06771149 34 725788
2006-04-13 UPLOAD filename1.txt 0000000000-06-017577 5554
2006-04-07 4 PRIMARY DOCUMENT 0001243428-06-000001 5742
2006-03-31 NT 10-K viral-nt10k_123105.htm 0001020488-06-000079 000-26875 06724540 34 13235
2006-03-30 8-K viral-8k_032906.htm 2.01,2.03,3.02,9.01 0001020488-06-000075 000-26875 06720035 34 781599
2006-03-30 8-K viral-8k_032806.htm 3.02 0001020488-06-000073 000-26875 06720020 34 18297
2006-03-27 8-K/A viral-8ka_030906.htm 4.01,9.01 0001020488-06-000063 000-26875 06710357 34 28329
2006-03-24 CORRESP filename1.htm 0001020488-06-000067 23908
2006-03-24 CORRESP filename1.htm 0001020488-06-000065 96279
2006-03-20 UPLOAD filename1.pdf 0000000000-06-013199 36850
2006-03-15 8-K viral-8k_030906.htm 4.01,9.01 0001020488-06-000054 000-26875 06688899 34 24224
2006-03-14 REGDEX/A AUTO-GENERATED PAPER DOCUMENT 06 9999999997-06-010559 021-66880 06027782 34 1814
2006-03-13 3 PRIMARY DOCUMENT 0001231341-06-000001 4475
2006-03-09 CORRESP filename1.htm 0001020488-06-000048 10317
2006-02-22 8-K viral-8k_021606.htm 5.02 0001020488-06-000028 000-26875 06636395 34 12594
2006-02-06 REGDEX/A AUTO-GENERATED PAPER DOCUMENT 06 9999999997-06-004856 021-66880 06024117 34 1814
2006-01-17 8-K viral-8k_011706.htm 7.01,9.01 0001020488-06-000008 000-26875 06532011 34 148328
2005-12-09 8-K viral-8k_120505.htm 3.02,9.01 0001020488-05-000206 000-26875 051256484 34 297067
2005-12-06 4 PRIMARY DOCUMENT 0001309772-05-000002 11561
2005-11-29 10QSB viralgen10qsb_093005.htm 0001020488-05-000201 000-26875 051230816 34 222450
2005-11-15 NT 10-Q viralnt10q_093005.htm 0001020488-05-000190 000-26875 051204150 34 15420
2005-11-14 CORRESP filename1.htm 0001020488-05-000188 25419
2005-11-03 CORRESP filename1.htm 0001020488-05-000178 7351
2005-10-31 REGDEX AUTO-GENERATED PAPER DOCUMENT 06 9999999997-05-045030 021-66880 05070425 34 1812
2005-10-24 8-K viralgen-8k_101805.htm 2.01,2.03,3.02,9.01 0001020488-05-000170 000-26875 051151562 34 252501
2005-10-20 4 PRIMARY DOCUMENT 0001327918-05-000002 5695
2005-10-05 CORRESP filename1.htm 0001020488-05-000166 13455
2005-10-04 CORRESP filename1.htm 0001020488-05-000164 13476
2005-08-22 10QSB viral-10qsb_063005.htm 0001020488-05-000151 000-26875 051042762 34 330547
2005-08-15 NT 10-Q viralgen-nt10q_063005.htm 0001020488-05-000137 000-26875 051024406 34 16578
2005-08-10 8-K viralgen-8k_081005.htm 7.01,9.01 0001020488-05-000133 000-26875 051014090 34 113420
2005-08-02 4 PRIMARY DOCUMENT 0001278333-05-000001 5753
2005-07-28 3 PRIMARY DOCUMENT 0001334030-05-000001 4505
2005-07-25 REGDEX/A AUTO-GENERATED PAPER DOCUMENT 06 9999999997-05-033221 021-66880 05062091 34 1818
2005-06-01 8-K viralgen-8k_052505.htm 3.02,5.02 0001020488-05-000080 000-26875 05870683 34 18921
2005-05-27 3 PRIMARY DOCUMENT 0001327918-05-000001 5348
2005-05-18 10QSB viralgen10qsb-033105.htm 0001020488-05-000074 000-26875 05840513 34 284638
2005-05-17 NT 10-Q viralgen-nt10q_033105.htm 0001020488-05-000068 000-26875 05837646 34 16548
2005-04-29 8-K viralgen.htm 3.02 0001020488-05-000058 000-26875 05786861 34 14377
2005-04-05 10KSB viralgen_10ksb123104.htm 0001020488-05-000048 000-26875 05733005 34 1708377
2005-04-01 NT 10-K viral_nt10k-123104.htm 0001020488-05-000046 000-26875 05724072 34 16555
2005-02-15 5 PRIMARY DOCUMENT 0001309772-05-000001 7366
2004-12-21 8-K viralgen_8k-121504.htm 1.01 0001020488-04-000123 000-26875 041217353 34 15869
2004-12-16 SC 13D lefebvre_111704-sched13d.htm 0001020488-04-000121 005-62091 041207463 34 36311
2004-12-07 8-K viralgen8k_120104.htm 3.02 0001020488-04-000119 000-26875 041187117 34 12278
2004-12-06 8-K/A viralgen8ka-092004.htm 9.01 0001020488-04-000117 000-26875 041186723 34 228937
2004-12-03 3/A PRIMARY DOCUMENT 0001020488-04-000113 4812
2004-11-23 8-K viralgen8k_111704.htm 3.02 0001020488-04-000097 000-26875 041163120 34 11244
2004-11-15 10QSB viralgen10qsb_090304.htm 0001020488-04-000089 000-26875 041143809 34 306051
2004-10-27 DEF 14C viralgendef14c102704.htm 0001020488-04-000076 000-26875 041099554 34 27963
2004-10-22 4 PRIMARY DOCUMENT 0001278334-04-000002 20513
2004-10-22 4 PRIMARY DOCUMENT 0001278333-04-000001 22682
2004-10-21 4 PRIMARY DOCUMENT 0001243428-04-000001 76053
2004-10-18 8-K viralgen8kcurrentreport.htm 3.02,9.01 0001020488-04-000072 000-26875 041083613 34 94375
2004-10-05 8-K/A viralgen8k-a09202004.htm 2.01,3.02,5.01 0001020488-04-000066 000-26875 041063888 35807
2004-10-04 PRE 14C viralgen14cinfo09202004.htm 0001020488-04-000064 000-26875 041062986 29613
2004-09-28 8-K viralten8krevised0904.htm 2.01,3.02,5.01 0001020488-04-000058 000-26875 041050286 168415
2004-09-01 REGDEX AUTO-GENERATED PAPER DOCUMENT 06 9999999997-04-035785 021-66880 04041772 1812
2004-08-16 10QSB 10-QSB ENDED JUNE 30, 2004 0001038838-04-000720 000-26875 04978621 97429
2004-06-28 REGDEX AUTO-GENERATED PAPER DOCUMENT 06 9999999997-04-027542 021-66880 04034240 1783
2004-05-25 10QSB 10-QSB ENDED MARCH 31, 2004 0001038838-04-000491 000-26875 04830057 82042
2004-05-20 4 PRIMARY DOCUMENT 0001243229-04-000003 9901
2004-05-20 5/A PRIMARY DOCUMENT 0001243229-04-000002 6056
2004-05-17 NT 10-Q EXTENSION FOR FILING 10-QSB ENDED MARCH 31, 2004 0001038838-04-000447 000-26875 04812206 5576
2004-05-11 10KSB 10-KSB YEAR ENDED DECEMBER 31, 2003 0001038838-04-000414 000-26875 04795923 497280
2004-03-29 NT 10-K fm12b-25_1203.txt 0001016193-04-000024 000-26875 04695791 5234
2004-02-25 5 PRIMARY DOCUMENT 0001243229-04-000001 5774
2004-02-24 4 PRIMARY DOCUMENT 0001278334-04-000001 4898
2004-02-23 4 PRIMARY DOCUMENT 0001278335-04-000002 9744
2004-02-23 3 PRIMARY DOCUMENT 0001278335-04-000001 3990
2003-12-17 10QSB tenq-0903.txt 0001016193-03-000127 000-26875 031060741 69782
2003-11-14 NT 10-Q q12b-25_0903.txt 0001016193-03-000113 000-26875 031000904 5300
2003-09-12 10QSB tenq-0603.txt 0001016193-03-000096 000-26875 03894403 71815
2003-08-15 NT 10-Q b1225q-0603.txt 0001016193-03-000090 000-26875 03850070 5282
2003-07-29 SC 13D sched13-0603.txt 0001016193-03-000081 005-62091 03808828 17563
2003-07-11 3 PRIMARY DOCUMENT 0001243229-03-000001 4940
2003-06-18 8-K fm8-k_0603.txt 1,7 0001016193-03-000072 000-26875 03749129 217678
2003-06-05 3 PRIMARY DOCUMENT 0001115221-03-000001 3856
2003-05-21 10QSB tenq-0303.txt 0001016193-03-000065 000-26875 03714326 106133
2003-05-16 NT 10-Q b12-25q.txt 0001016193-03-000062 000-26875 03707453 5275
2003-05-01 10KSB tenk-1202.txt 0001016193-03-000051 000-26875 03676423 151968
2003-03-31 NT 10-K b12-25k_02.txt 0001016193-03-000035 000-26875 03629629 5251
2002-11-20 10QSB tenq0902.txt 0001016193-02-000147 000-26875 02834365 68334
2002-11-14 NT 10-Q b12q-0902.txt 0001016193-02-000138 000-26875 02823248 5299
2002-09-25 8-K/A fm8ka-0802.txt 5,7 0001016193-02-000118 000-26875 02772058 6640
2002-08-23 8-K fm8k-0802.txt 5,7 0001016193-02-000100 000-26875 02747210 46738
2002-08-19 10QSB VIRAL JUNE 2002 10-QSB 0001016193-02-000098 000-26875 02742180 54691
2002-08-14 NT 10-Q b12-25q.txt 0001016193-02-000094 000-26875 02736380 5249
2002-05-28 10QSB tenq0302.txt 0001016193-02-000061 000-26875 02663789 53056
2002-05-15 NT 10-Q b12-0302.txt 0001016193-02-000052 000-26875 02649296 5126
2002-04-24 10KSB tenk-01.txt 0001016193-02-000035 000-26875 02619822 265316
2002-04-01 NT 10-K b12-25k.txt 0001016193-02-000022 000-26875 02595120 5173
2002-01-22 10QSB VIRAL GENETICS 10-QSB 0001013176-02-000010 000-26875 02513932 55514
2002-01-14 NT 10-Q VIRAL GENETICS 12B-25 11-30-01 0001013176-02-000007 000-26875 2508453 5075
2001-10-30 10KSB/A 5 STARLIVING 10-KSB AMENDMENT 2 0001013176-01-500203 000-26875 1770089 59514
2001-10-30 DEF 14C 5 STARLIVING DEF14C 10-30-2001 0001013176-01-500201 000-26875 1769924 17723
2001-10-18 PRE 14C 5 STARLIVING ONLINE, INC. 0001013176-01-500198 000-26875 1761462 17573
2001-10-18 SC 14F1 5 STARLIVING ONLINE, INC. 14F-1 0001013176-01-500197 005-62091 1761283 13338
2001-10-17 8-K 5 STAR LIVING 8K 10-2001 1,2,7 0001013176-01-500196 000-26875 1760681 89938
2001-10-17 10KSB/A 5 STAR LIVING 10-KSB AM. 1 0001013176-01-500194 000-26875 1760671 59409
2001-10-15 10QSB 5STAR LIVING ONLINE 10-QSB 8-31-2001 0001013176-01-500193 000-26875 1759233 46913
2001-10-12 NTN 10K 5 STARLIVING ONLINE, INC. FORM NT-10K 0000897101-01-500660 000-26875 1758239 8633
2001-10-12 NT 10-Q 5 STAR LIVING ONLINE, INC. FORM NT-10Q 0000897101-01-500659 000-26875 1758237 8632
2001-08-28 10-K 5 STAR LIVING ONLINE, INC FORM 10-K 0001052918-01-500082 000-26875 1724478 63440
2001-08-08 PREM14A 5 STARLIVING ONLINE, INC. PRELIM MERGER PROXY 0000897101-01-500472 000-26875 1700401 93439
2001-07-16 NT 10-Q 5 STAR LIVING ONLINE, INC FORM 12B-25 0001052918-01-500058 000-26875 1682187 5514
2001-06-05 PRER14A 5 STARLIVING ONLINE REVISED PRELIM PROXY STMT 0000897101-01-500345 000-26875 1654189 224819
2001-06-01 PRES14A 5 STARLIVING ONLINE, INC. PRES14A 0000897101-01-500343 000-26875 1652991 218817
2001-04-13 10-Q 0001.txt 0001052918-01-000074 000-26875 1602192 42115
2001-01-16 10-Q 0001.txt 0001052918-01-000016 000-26875 1508378 40821
2000-10-13 10-Q 0001.txt 0001091326-00-000017 000-26875 740201 25975
2000-08-29 10-K 0001.txt 0001091326-00-000015 000-26875 712789 27779
2000-04-10 10-Q 0001091326-00-000004 0001091326-00-000004 000-26875 596579 13355
2000-02-09 DEFS14A 0000897101-00-000089 0000897101-00-000089 000-26875 528512 22391
2000-01-26 10-Q 0000897101-00-000051 0000897101-00-000051 000-26875 513453 16913
1999-10-28 10-Q 0000897101-99-001009 0000897101-99-001009 000-26875 99735790 19749
1999-07-29 10SB12G 0000897101-99-000739 0000897101-99-000739 000-26875 99672692 72399

Latest XBRL company facts

One latest value per concept from companyfacts (127 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 107.88M 2015-11-17 2015 Q3 10-Q 2015-11-19 0001019687-15-004252
dei EntityPublicFloat Entity Public Float USD 1.26M 2014-12-31 2014 FY 10-K 2015-04-15 0001019687-15-001463
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 836,975 2015-09-30 2015 Q3 10-Q 2015-11-19 0001019687-15-004252
us-gaap AccretionOfDiscount Accretion of Discount (Deprecated 2016-01-31) USD 1.25M 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-19 0001019687-15-004252
us-gaap AccruedInsuranceCurrent Accrued Insurance, Current USD 0 2015-09-30 2015 Q3 10-Q 2015-11-19 0001019687-15-004252
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 134,879 2015-09-30 2015 Q3 10-Q 2015-11-19 0001019687-15-004252
us-gaap AccruedRoyaltiesCurrent Accrued Royalties, Current USD 20,000 2014-12-31 2015 Q3 10-Q 2015-11-19 0001019687-15-004252
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 104.85M 2015-09-30 2015 Q3 10-Q 2015-11-19 0001019687-15-004252
us-gaap AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature USD 294,907 2013-01-01 2013-12-31 2014 FY 10-K 2015-04-15 0001019687-15-001463
us-gaap AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition USD 688,179 2014-01-01 2014-12-31 2014 FY 10-K 2015-04-15 0001019687-15-001463
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 150,000 2013-01-01 2013-12-31 2014 FY 10-K 2015-04-15 0001019687-15-001463
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 239,807 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-19 0001019687-15-004252
us-gaap AmortizationOfDebtDiscountPremium Amortization of Debt Discount (Premium) USD 9.27M 1995-07-11 2014-09-30 2014 Q3 10-Q 2014-11-13 0001019687-14-004238
us-gaap AssetImpairmentCharges Asset Impairment Charges USD 475,000 1995-07-11 2014-12-31 2014 FY 10-K 2015-04-15 0001019687-15-001463
us-gaap Assets Assets USD 1.12M 2015-09-30 2015 Q3 10-Q 2015-11-19 0001019687-15-004252
us-gaap AssetsCurrent Assets, Current USD 40,326 2015-09-30 2015 Q3 10-Q 2015-11-19 0001019687-15-004252
us-gaap AssetsNoncurrent Assets, Noncurrent USD 1.08M 2015-09-30 2015 Q3 10-Q 2015-11-19 0001019687-15-004252
us-gaap Cash Cash USD 22,919 2015-09-30 2015 Q3 10-Q 2015-11-19 0001019687-15-004252
us-gaap CashPeriodIncreaseDecrease Cash, Period Increase (Decrease) USD -11,073 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-19 0001019687-15-004252
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 0.35 2014-12-31 2014 FY 10-K 2015-04-15 0001019687-15-001463
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 137.05M 2014-12-31 2014 FY 10-K 2015-04-15 0001019687-15-001463
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2015-09-30 2015 Q3 10-Q 2015-11-19 0001019687-15-004252
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 150.00M 2015-09-30 2015 Q3 10-Q 2015-11-19 0001019687-15-004252
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 101.50M 2015-09-30 2015 Q3 10-Q 2015-11-19 0001019687-15-004252
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 101.50M 2015-09-30 2015 Q3 10-Q 2015-11-19 0001019687-15-004252
us-gaap CommonStockValue Common Stock, Value, Issued USD 10,150 2015-09-30 2015 Q3 10-Q 2015-11-19 0001019687-15-004252
us-gaap ContractualObligation Contractual Obligation USD 594,000 2014-12-31 2014 FY 10-K 2015-04-15 0001019687-15-001463
us-gaap ConvertibleDebtCurrent Convertible Debt, Current USD 1.24M 2015-09-30 2015 Q3 10-Q 2015-11-19 0001019687-15-004252
us-gaap ConvertiblePreferredStockSharesReservedForFutureIssuance Convertible Preferred Stock, Shares Reserved for Future Issuance shares 161,924 2014-12-31 2014 FY 10-K 2015-04-15 0001019687-15-001463
us-gaap CostsAndExpenses Costs and Expenses USD 2.19M 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-19 0001019687-15-004252
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD 2.10M 2014-01-01 2014-12-31 2014 FY 10-K 2015-04-15 0001019687-15-001463
us-gaap DebtInstrumentConvertibleBeneficialConversionFeature Debt Instrument, Convertible, Beneficial Conversion Feature USD -71,500 1995-07-11 2014-12-31 2014 FY 10-K 2015-04-15 0001019687-15-001463
us-gaap DebtIssuanceCosts Debt Issuance Cost (Deprecated 2016-01-31) USD 13.34M 1995-07-11 2014-12-31 2014 FY 10-K 2015-04-15 0001019687-15-001463
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 16.11M 2014-12-31 2014 FY 10-K 2015-04-15 0001019687-15-001463
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 0 2014-12-31 2014 FY 10-K 2015-04-15 0001019687-15-001463
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 16.11M 2014-12-31 2014 FY 10-K 2015-04-15 0001019687-15-001463
us-gaap Depreciation Depreciation USD 1.65M 1995-07-11 2014-12-31 2014 FY 10-K 2015-04-15 0001019687-15-001463
us-gaap DepreciationAndAmortization Depreciation, Depletion and Amortization, Nonproduction USD 1.65M 1995-07-11 2014-12-31 2014 FY 10-K 2015-04-15 0001019687-15-001463
us-gaap DerivativeGainLossOnDerivativeNet Derivative, Gain (Loss) on Derivative, Net USD -318,119 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-19 0001019687-15-004252
us-gaap DerivativeLiabilities Derivative Liability USD -658,141 2014-12-31 2014 FY 10-K 2015-04-15 0001019687-15-001463
us-gaap DerivativeLiabilitiesCurrent Derivative Liability, Current USD 940,040 2015-09-30 2015 Q3 10-Q 2015-11-19 0001019687-15-004252
us-gaap DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) USD 105.54M 2014-09-30 2014 Q3 10-Q 2014-11-13 0001019687-14-004238
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.06 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-19 0001019687-15-004252
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0.34 2014-01-01 2014-12-31 2014 FY 10-K 2015-04-15 0001019687-15-001463
us-gaap EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity Embedded Derivative, No Longer Bifurcated, Amount Reclassified to Stockholders' Equity USD 845,640 2014-01-01 2014-12-31 2014 FY 10-K 2015-04-15 0001019687-15-001463
us-gaap FairValueAssumptionsExpectedDividendRate Fair Value Assumptions, Expected Dividend Rate (Deprecated 2018-01-31) pure 0 2014-01-01 2014-12-31 2014 FY 10-K 2015-04-15 0001019687-15-001463
us-gaap FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Gain (Loss) Included in Earnings USD -679,659 2014-01-01 2014-12-31 2014 FY 10-K 2015-04-15 0001019687-15-001463
us-gaap FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPurchasesSalesIssuesSettlements Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Purchases, Sales, Issues, Settlements USD 845,640 2014-01-01 2014-12-31 2014 FY 10-K 2015-04-15 0001019687-15-001463
us-gaap FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationTransfersNet Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Transfers, Net USD 2.00M 1995-07-11 2014-12-31 2014 FY 10-K 2015-04-15 0001019687-15-001463
us-gaap FiniteLivedIntangibleAssetsNet Finite-Lived Intangible Assets, Net USD 1.08M 2015-09-30 2015 Q3 10-Q 2015-11-19 0001019687-15-004252
us-gaap FiniteLivedIntangibleAssetsPeriodIncreaseDecrease Finite-Lived Intangible Assets, Period Increase (Decrease) USD -5.21M 1995-07-11 2014-12-31 2014 FY 10-K 2015-04-15 0001019687-15-001463
us-gaap GainLossOnSaleOfOtherAssets Gain (Loss) on Disposition of Other Assets USD 1.31M 1995-07-11 2014-12-31 2014 FY 10-K 2015-04-15 0001019687-15-001463
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 384,240 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-19 0001019687-15-004252
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 0 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-19 0001019687-15-004252
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2014-01-01 2014-12-31 2014 FY 10-K 2015-04-15 0001019687-15-001463
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 1.25M 2014-01-01 2014-12-31 2014 FY 10-K 2015-04-15 0001019687-15-001463
us-gaap IncomeTaxReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount USD 856,215 2014-01-01 2014-12-31 2014 FY 10-K 2015-04-15 0001019687-15-001463
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 156,763 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-19 0001019687-15-004252
us-gaap IncreaseDecreaseInAccountsPayableRelatedParties Increase (Decrease) in Accounts Payable, Related Parties USD -112,475 1995-07-11 2014-12-31 2014 FY 10-K 2015-04-15 0001019687-15-001463
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD 3,897 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-19 0001019687-15-004252
us-gaap IncreaseDecreaseInAccruedSalaries Increase (Decrease) in Accrued Salaries USD 771,744 1995-07-11 2014-12-31 2014 FY 10-K 2015-04-15 0001019687-15-001463
us-gaap IncreaseDecreaseInCustomerAdvances Increase (Decrease) in Customer Advances USD 136,000 1995-07-11 2014-12-31 2014 FY 10-K 2015-04-15 0001019687-15-001463
us-gaap IncreaseDecreaseInDepositOtherAssets Increase (Decrease) in Deposit Assets USD -1.97M 1995-07-11 2014-12-31 2014 FY 10-K 2015-04-15 0001019687-15-001463
us-gaap IncreaseDecreaseInDerivativeLiabilities Increase (Decrease) in Derivative Liabilities USD 318,119 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-19 0001019687-15-004252
us-gaap IncreaseDecreaseInDueToRelatedParties Increase (Decrease) in Due to Related Parties USD 74,283 1995-07-11 2014-12-31 2014 FY 10-K 2015-04-15 0001019687-15-001463
us-gaap IncreaseDecreaseInFinanceReceivables Increase (Decrease) in Finance Receivables USD 0 2015-01-01 2015-03-31 2015 Q1 10-Q 2015-05-20 0001019687-15-002045
us-gaap IncreaseDecreaseInInterestPayableNet Increase (Decrease) in Interest Payable, Net USD 142,488 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-19 0001019687-15-004252
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD -195,868 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-19 0001019687-15-004252
us-gaap InterestAndOtherIncome Interest and Other Income USD 9,392 1995-07-11 2014-12-31 2014 FY 10-K 2015-04-15 0001019687-15-001463
us-gaap InterestExpense Interest Expense USD 1.40M 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-19 0001019687-15-004252
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 0 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-19 0001019687-15-004252
us-gaap InterestPayableCurrent Interest Payable, Current USD 165,208 2015-09-30 2015 Q3 10-Q 2015-11-19 0001019687-15-004252
us-gaap IssuanceOfStockAndWarrantsForServicesOrClaims Issuance of Stock and Warrants for Services or Claims USD 0 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-19 0001019687-15-004252
us-gaap LeaseAndRentalExpense Operating Leases, Rent Expense USD 0 2014-01-01 2014-12-31 2014 FY 10-K 2015-04-15 0001019687-15-001463
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 1.12M 2015-09-30 2015 Q3 10-Q 2015-11-19 0001019687-15-004252
us-gaap LiabilitiesCurrent Liabilities, Current USD 5.46M 2015-09-30 2015 Q3 10-Q 2015-11-19 0001019687-15-004252
us-gaap MinorityInterest Stockholders' Equity Attributable to Noncontrolling Interest USD 638,707 2015-09-30 2015 Q3 10-Q 2015-11-19 0001019687-15-004252
us-gaap NetCashProvidedByUsedInFinancingActivitiesContinuingOperations Net Cash Provided by (Used in) Financing Activities, Continuing Operations USD 439,851 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-19 0001019687-15-004252
us-gaap NetCashProvidedByUsedInInvestingActivitiesContinuingOperations Net Cash Provided by (Used in) Investing Activities, Continuing Operations USD -6.61M 1995-07-11 2014-12-31 2014 FY 10-K 2015-04-15 0001019687-15-001463
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD -450,924 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-19 0001019687-15-004252
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -3.87M 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-19 0001019687-15-004252
us-gaap NetIncomeLossAttributableToNoncontrollingInterest Net Income (Loss) Attributable to Noncontrolling Interest USD -25,806 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-19 0001019687-15-004252
us-gaap NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance Noncontrolling Interest, Increase from Subsidiary Equity Issuance USD 60,000 2013-01-01 2013-12-31 2014 FY 10-K 2015-04-15 0001019687-15-001463
us-gaap NotesPayableRelatedPartiesClassifiedCurrent Notes Payable, Related Parties, Current USD 2.15M 2015-09-30 2015 Q3 10-Q 2015-11-19 0001019687-15-004252
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -2.19M 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-19 0001019687-15-004252
us-gaap OperatingLossCarryforwards Operating Loss Carryforwards USD 47.40M 2014-12-31 2014 FY 10-K 2015-04-15 0001019687-15-001463
us-gaap OtherCommitmentDueAfterFifthYear Other Commitment, to be Paid, after Year Five USD 250,000 2014-12-31 2015 Q3 10-Q 2015-11-19 0001019687-15-004252
us-gaap OtherCommitmentDueInFourthYear Other Commitment, to be Paid, Year Four USD 187,000 2014-12-31 2015 Q3 10-Q 2015-11-19 0001019687-15-004252
us-gaap OtherCommitmentDueInNextTwelveMonths Other Commitment, to be Paid, Year One USD 20,000 2014-12-31 2015 Q3 10-Q 2015-11-19 0001019687-15-004252
us-gaap OtherCommitmentDueInSecondYear Other Commitment, to be Paid, Year Two USD 87,500 2014-12-31 2015 Q3 10-Q 2015-11-19 0001019687-15-004252
us-gaap OtherCommitmentDueInThirdYear Other Commitment, to be Paid, Year Three USD 125,000 2014-12-31 2015 Q3 10-Q 2015-11-19 0001019687-15-004252
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD -1.71M 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-19 0001019687-15-004252
us-gaap PaymentsForTenantImprovements Payments for Tenant Improvements USD 1.04M 1995-07-11 2014-12-31 2014 FY 10-K 2015-04-15 0001019687-15-001463
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 361,665 1995-07-11 2014-12-31 2014 FY 10-K 2015-04-15 0001019687-15-001463
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2015-09-30 2015 Q3 10-Q 2015-11-19 0001019687-15-004252
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 20.00M 2015-09-30 2015 Q3 10-Q 2015-11-19 0001019687-15-004252
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 9.72M 2015-09-30 2015 Q3 10-Q 2015-11-19 0001019687-15-004252
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 9.72M 2015-09-30 2015 Q3 10-Q 2015-11-19 0001019687-15-004252
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 972 2015-09-30 2015 Q3 10-Q 2015-11-19 0001019687-15-004252
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 17,407 2015-09-30 2015 Q3 10-Q 2015-11-19 0001019687-15-004252
us-gaap ProceedsFromConvertibleDebt Proceeds from Convertible Debt USD 273,000 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-19 0001019687-15-004252
us-gaap ProceedsFromIssuanceOfLongTermDebt Proceeds from Issuance of Long-term Debt USD 236,200 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-19 0001019687-15-004252
us-gaap ProceedsFromIssuanceOrSaleOfEquity Proceeds from Issuance or Sale of Equity USD 11.08M 1995-07-11 2014-12-31 2014 FY 10-K 2015-04-15 0001019687-15-001463
us-gaap ProceedsFromLinesOfCredit Proceeds from Lines of Credit USD 5,713 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-19 0001019687-15-004252
us-gaap ProceedsFromNotesPayable Proceeds from Notes Payable USD 267,000 1995-07-11 2014-12-31 2014 FY 10-K 2015-04-15 0001019687-15-001463
us-gaap ProceedsFromRelatedPartyDebt Proceeds from Related Party Debt USD 9.38M 1995-07-11 2014-12-31 2014 FY 10-K 2015-04-15 0001019687-15-001463
us-gaap ProceedsFromRepaymentsOfRelatedPartyDebt Proceeds from (Repayments of) Related Party Debt USD -55,767 2015-01-01 2015-06-30 2015 Q2 10-Q 2015-08-19 0001019687-15-003202
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 173,061 1995-07-11 2014-12-31 2014 FY 10-K 2015-04-15 0001019687-15-001463
us-gaap ProfessionalAndContractServicesExpense Professional and Contract Services Expense USD 16,150 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-19 0001019687-15-004252
us-gaap ProfessionalFees Professional Fees USD 403,119 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-19 0001019687-15-004252
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -3.90M 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-19 0001019687-15-004252
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 0 2015-09-30 2015 Q3 10-Q 2015-11-19 0001019687-15-004252
us-gaap RepaymentsOfConvertibleDebt Repayments of Convertible Debt USD 27,884 2015-01-01 2015-03-31 2015 Q1 10-Q 2015-05-20 0001019687-15-002045
us-gaap RepaymentsOfLinesOfCredit Repayments of Lines of Credit USD 1.69M 1995-07-11 2014-12-31 2014 FY 10-K 2015-04-15 0001019687-15-001463
us-gaap RepaymentsOfRelatedPartyDebt Repayments of Related Party Debt USD 75,062 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-19 0001019687-15-004252
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 462,589 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-19 0001019687-15-004252
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -109.84M 2015-09-30 2015 Q3 10-Q 2015-11-19 0001019687-15-004252
us-gaap Revenues Revenues USD 0 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-19 0001019687-15-004252
us-gaap SalariesAndWages Salary and Wage, NonOfficer, Excluding Cost of Good and Service Sold USD 919,093 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-19 0001019687-15-004252
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 1.89M 1995-07-11 2014-12-31 2014 FY 10-K 2015-04-15 0001019687-15-001463
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant shares 18.00M 2015-09-30 2015 Q3 10-Q 2015-11-19 0001019687-15-004252
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures shares 4.50M 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-19 0001019687-15-004252
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD -4.34M 2015-09-30 2015 Q3 10-Q 2015-11-19 0001019687-15-004252
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 2.41M 2014-01-01 2014-12-31 2014 FY 10-K 2015-04-15 0001019687-15-001463
us-gaap StockIssuedDuringPeriodValueShareBasedCompensation Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture USD 322,458 2014-01-01 2014-12-31 2014 FY 10-K 2015-04-15 0001019687-15-001463
us-gaap UnsecuredDebt Unsecured Debt USD 160,250 2014-12-31 2014 FY 10-K 2015-04-15 0001019687-15-001463
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 67.72M 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-19 0001019687-15-004252

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →